06/13/2016 - 1:13pm

The vaccine — the first FDA-approved cholera prevention vaccine — is aimed at travelers headed to countries with inadequate water and sewage treatment and poor sanitation.

06/13/2016 - 12:59pm

The peak percentage of outpatient visits for ILI was 3.6% and occurred during the week ending March 12, 2016.

06/13/2016 - 12:13pm

Incorporating the word “Alliance” into the association's new brand, in particular, reflects HDA's role as a convener of the supply chain — in the United States and now abroad, HDA stated. 

06/10/2016 - 10:17am

The new weight limit for the 10- and 25-mg oral tablets is now at least 30 kg, down from at least 40 kg for patients aged 6 to less than 12 years. 

06/10/2016 - 9:59am

Upsher-Smith’s Qudexy XR has gained tentative approval from the Food and Drug Administration as a preventative therapy for migraine headaches.

06/08/2016 - 12:23pm
The program, RespiPoints, is being undertaken in partnership with HealthPrize Technologies. 
06/07/2016 - 2:42pm

Under the partnership, Ultragenyx will initially receive an exclusive license for one of Takeda’s preclinical product candidates in a pre-determined field of use, along with the option to co-develop and co-commercialize the candidate in other therapeutic areas.

06/06/2016 - 12:33pm

The drug is indicated to treat hypertension to lower blood pressure, and the company said it is the first fixed-dose combination of a beta-blocker and an angiotensin II receptor blocker in the U.S.

06/01/2016 - 1:20pm
The topical steroid is indicated to treat mild to moderate plaque psoriasis in patients older than 18 years of age.